Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced‐stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|169|4|544-551

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.4, 2015-05, pp. : 544-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Prognostic Impact of Absolute Lymphocyte and Monocyte Counts at Diagnosis of Diffuse Large B-Cell Lymphoma in the Rituximab Era

By  

Acta Haematologica, Vol. 130, Iss. 4, 2013-07 ,pp. : 242-246

Karger

Access to resources Recommend Favorite

Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced‐stage follicular lymphoma: A cost‐effectiveness analysis

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2637-2645

John Wiley & Sons Inc

Access to resources Recommend Favorite

The prognostic value of positron emission tomography performed after two courses (INTERIM‐PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL)

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : 499-503

John Wiley & Sons Inc

Access to resources Recommend Favorite

Absolute monocyte count at diagnosis could improve the prognostic role of early FDG‐PET in classical Hodgkin lymphoma patients

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 600-602

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Value of Absolute Lymphocyte Counts before Bortezomib-Dexamethasone Therapy in Relapsed Multiple Myeloma Patients

By  

Acta Haematologica, Vol. 124, Iss. 1, 2010-07 ,pp. : 34-39

Karger

Access to resources Recommend Favorite